SCREENING OF SYNTHETIC NEW HETEROCYCLIC DERIVATIVES OF 3- FORMYL-4-HYDROXYCOUMARIN FOR ANTI-INFLAMMATORY ACTIVITY IN ALBINO RATS by ZEBA N SIDDIQUI, ANIL KUMAR, RAZI AHMAD, MOHAMMAD ASAD
 JPRHC | July 2009 | Vol. 1 | No.1 | 46-62                                                                           Page 46 
 
JPRHC                                                                                                                                
 
                                                                                                                           Research Article 
 
SCREENING OF SYNTHETIC NEW HETEROCYCLIC DERIVATIVES OF 3-
FORMYL-4-HYDROXYCOUMARIN FOR ANTI-INFLAMMATORY ACTIVITY 
IN ALBINO RATS 
RAZI AHMAD, MOHAMMAD ASAD*, ZEBA N SIDDIQUI*, ANIL KUMAR 
For author affiliations, see end of text 





Coumarins have multiple biological activities; various coumarin-related derivatives are 
recognized as inhibitors of the lipoxygenase and cycloxygenase pathways of arachidonate 
metabolism. Several natural or synthetic coumarins with various hydroxyl and other substitutes 
were found to inhibit lipid peroxidation and to scavenge hydroxyl radical and superoxide anion 
and to influence processes involving free radical mediated injury. The heterocyclic derivatives of 
3-formyl-4-hydoxycoumarin were found to present significant anti-inflammatory effect, the 
compounds inhibited formalin induced hind paw edema and they also significantly suppressed 
the formation of granuloma tissue in cotton pellet induced chronic model of inflammation. The 
result showed that the anti-inflammatory (both acute & chronic) effect of the test compound Ib is 
comparable to that of standard Antiinflammatory drug Diclofenac Sodium. 
Keywords: 3-Formyl-4-hydroxycoumarin derivatives; Coumarin; Anti-inflammatory. 
 




Coumarins show activities such as antifungal (Sangwan et al., 1990), anticoagulant 
(Stahman et al., 1941), antibacterial (Honmantgad et al., 1985), analgesic, antipyretic, anti-
inflammatory and anti-arthritic (Santaqati et al., 1993; Kontogiorgis and Hadjipavlou-Litina, 
2005). Coumarins are reported to be used in the treatment of vitiligo, psoriasis and other dermal 
diseases. The physiological properties of natural and synthetic Coumarins have been reviewed by 
various workers (Soine, 1964).  In recent times [1]benzopyran-2[H]-ones have been extensively 
used as intermediates for dyes, pesticides and pharmaceuticals (Hagen and Kohler, 1981) as well 
as in perfume formulations (Pozdnev, 1987; Pozdnev, 1990) and in enzymology as biological 
probes (Tamura et al., 1982). The objective of the present study was to screen three, 3-(3-methyl 
pyrazol-5 yl)-pyrano[3,2-c][1] benzopyran 2,5-dione, 3-(3- methyl-1-phenyl pyrazol-5-yl)- 
pyrano [3,2-c] benzopyran-2, 5-dione and  -(3-methyl-1-benzothiazolopyrazol-5-yl)-pyrano[3,2-
c][1] benzopyran-2,5-dione (synthesized by us) for anti-inflammatory activity in albino rats. 
 
 2. MATERIALS AND METHODS           
 2.1 Chemicals and test compounds  
  Following heterocyclic compounds were synthesized in the research laboratory of 
Department of Chemistry and studied for their physiochemical and spectral properties (Siddiqui 
and Asad, 2006). They were tested for acute and chronic anti-inflammatory activity in animal 
models. 
  1. 3-Acetoacetyl pyrano [3,2-c] [1] benzopyran 2,5-dione (fig.1) 
 Was prepared from intramolecular translactonization of 4-hydroxycoumarins and triacetic acid 
lactone. The resulting compound which possessed a 1,3-diketone unit in its structure were 
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converted to pyrazoles by treatment with hydrazine, phenylhydrazine and 




















1a: R=H   (Hydrazine hydrate)






Fig 1: Structure of some novel new heterocyclic derivatives of 3-formyl-4-hydroxycoumarines 
synthesized and screened. 
 
 
1a. 3-(3-methyl pyrazol-5-yl)-pyrano[3,2-c][1] benzopyran 2,5-dione.  
1b. 3-(3- methyl-1-phenyl pyrazol-5-yl)- pyrano [3,2-c] benzopyran-2, 5-dione and   
1c. 3-(3-methyl-1-benzothiazolopyrazol-5-yl)-pyrano[3,2-c][1] benzopyran-2,5-dione 
The test compounds were dissolved in 2.5% DMSO (Dimethyl sulphoxide) prior to 
administration in different concentration so that animal received equal volume each time (5 
ml/kg).Dose selection of the test compound was based on preliminary trial carried out in our 
laboratory over a dose range 5 mg/kg to 40 mg/kg in geometric increasing order and maximal 
effect was found at the dose of 20 mg/kg.  
Drugs used: 
Formalin (Merck, India)  
Diclofenac (Novartis) 
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2.2. Experimental Animals  
Male Wistar Albino rats (weight 100–150 g) obtained from Laboratory Animal Breeding 
and Research Center Jamia Hamdard University New Delhi were used for the present study. The 
animals were given a week time to get acclimatized with laboratory conditions.The animals were 
housed in polypropylene cage (4 per cage) with sterilized paper cuttings as bedding material 
under laboratory conditions with control environment of temperature 22 ± 3 ºC, humidity  (60 % 
± 10 %) an 12 h light/dark cycle. They were given free access to food with standard rodent pellet 
diet (from Lipton India) and drinking water. 
The study protocol was approved by the institutional ethical committee. 
 
2.3. Experimental Protocol 
The following experimental models were used for test compounds.  
 
a.  Acute anti-inflammatory model (Paw edema induced by Formalin) 
           Method describe by Northover and Subramanian (1961) in which 0.05 ml of 3.5% 
Formalin in Normal Saline was injected in the subcutaneous tissue of the planter surface of right 
hind paw produced sub maximal degree of swelling. The paw volume was measured at 0, 0.5, 1, 
2, 3, 4 and 5 hour after injection of Formalin. The volume (in milliliters) of the inflamed paw 
was measured by standard volumetric technique, using a calibrated plethysmometer. The paw 
was immersed upto the tibiotarsic articulation (marked with ink) in a cylinder filled with 
mercury. The increased level, consequent on the increase of the mercury meniscus, was 
measured from the increase of dyed ethanol in a glass tube connected to the surface of the 
mercury so that variation of the mercury level corresponded to increases in the dyed ethanol in a 
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calibrated glass tube. The increase in volume of the paw was calculated by subtracting the initial 
volume from the volume obtained after formalin administration and expressed as paw volume 
increase over time (ml ± SD) and effect (percent of negative control) for each rat and each group 
was obtained as follows. 
                                              
                                               (Vt – Vo) control – (Vt –Vo) treated 
Percentage of inhibition =                                                               X 100 
                                                     (Vt – Vo) control 
 
(Vo = is average volume of right paw before injection of formalin i.e. at 0 h and Vt = is average 
volume of right paw after injection of formalin) 
Experimental design and drug treatment: Rats were divided into three groups of six rats each.  
Group I:  received 2.5% DMSO 1 h prior to formalin and served as control. 
Group II: received test compound (20mg/kg, orally) 1 h before injection of formalin. 
Group III:  received Diclofenac (5 mg/kg, orally) 1 h before injection of formalin. 
 
 
b. Chronic anti-inflammatory activity (Cotton pellets-induced granuloma test)  
                 The method described by D’Arcy et al., 1960 (Turner, 1965) was used. Under light 
ether anesthesia, sterile cotton pellets (10 ±1 mg) were implanted subcutaneously in the groin 
regions of the rats. The test compounds (20mg/kg), Diclofenac (5 mg/kg) and control vehicle 
2.5% DMSO (5ml/kg) were administered once daily orally for seven consecutive days from the 
day of cotton pellet implantation. The animals were anesthetized on the eighth day and cotton 
pellets were removed surgically and made free from fat and extraneous tissues. The wet weights 
of granuloma were estimated and than pellet were dried overnight at 60 ºC in hot-air oven to 
constant weight. The weight of the cotton pellet before implantation was subtracted from the 
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weight of the dried, dissected pellet. The mean weight was calculated for the pellets from a group 
of rats, and compared with the mean for a group of controls. Increment in the dry weight of the 
pellets was taken as measure of granuloma formation.  The difference in wet weight and dry 
weights of granuloma from control group to that of treated group indicated the anti-inflammatory 
activity. 
Experimental design and drug treatment: Rats were divided into three groups of six rats each.  
Group I:  received 2.5% DMSO (5ml/kg, orally) daily for seven days and served as control. 
Group II: received test compound (20mg/kg, orally) daily for seven days. 
Group III:  received Diclofenac (5 mg/kg, orally) daily for seven days 
c. Acute Toxicity study 
The acute oral toxicity was carried out as per the guideline set by the organization for the 
economic co-operation and development (OECD) received from the committee for the purpose 
of control and supervision of experimental animals (CPCSEA). 
Experimental design and drug treatment: (Bruce. R-D et al),  
Two rats (one from either sex) were dosed at predetermined [250, 500 and 1000 mg /kg 
dissolved in fixed amount (1.5 ml) of DMSO] and administered by stomach feeding cannula. 
They were observed continuously for the first 2 h for toxic symptoms and up to 24 h for 
mortality (Litchfield et al., 1949). If there was no mortality or if no more than one rat of either 
sex died at the highest level tested (1000 mg/kg) with the total of 10 rats (5/sex) dosed at 1000 
mg/kg and monitored for 7 days period, LD50 was considered to more than 1000 mg/kg. 
  
 
f. Statistical analysis  
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  All values are presented as mean ± S.E.M. of six rats and difference between means were 
assessed by one-way analysis of variance (ANOVA), followed by student’s t test. Difference 
between means were considered to be significant at P<0.05 as compare to control. 
 
3. RESULTS  
 
a. Acute inflammation model (formalin induced paw oedema) 
            The results of the anti-inflammatory effect of the test compounds on Formalin 
induced oedema in rat’s right hind paws are presented in Table 1&2. There was a gradual increase in 
oedema paw volume of rats in the control (Formalin treated). However, in the test groups, the 
compounds showed a significant reduction in the oedema paw volume. As indicated in Table 2, the 
significant antiinflammatory effect induced by test compounds Ia, Ib & Ic appeared at 1-2 h and 
progressively increased and reached a maximum 46.6%, 88.5% & 65.5% respectively at five 
hours, while the maximum Antiinflammatory effect of test compound I appeared at I h (60%). 
The Antiinflammatory effect induced by Diclofenac sodium progressively increased and reached 
a maximum (70.8%) at two hours. It was maintained up to five hours. 
  
 b. Cotton pellet induced granuloma (Chronic model) 
            
 In the chronic model (cotton pellet induced granuloma) the test compounds and Diclofenac 
sodium significantly (P<0.05) reduced both wet as well as dry weights in cotton pellet 
granuloma (Table 3). The effect of test compound Ib in both reducing wet weight and dry weight 
of cotton pellet induced granuloma was similar to that of Diclofenac sodium.  
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Table 1:  Effects of test compounds and Diclofenac on acute inflammation of paw oedema 
induced by formalin. 
 
 
The results given are mean ± S.E.M; number of animals used (n=6) *P value of < 0.05 was 
considered as significant in comparison to control 
 
c. Acute Toxicity study evaluation 
 
In acute toxicity study the test compounds did not show any toxicity and mortality up to 
maximum dose of 1000 mg/kg body weight in rats. No gross change in behavior was observed at 









   Test                                                                    Mean paw volume ± SEM (ml) 
Compound    Dose/kg       Before 
                                    Formalin               0.5 h                  1 h                  2 h                    3h                    4 h                      5 h 
 
DMSO      5 ml        0.71 ± 0.02      0.76 ± 0.02     0.86 ± 0.03      0.95 ± 0.02       1.02 ± 0.02       1.07 ± 0.04       1.23 ± 0.01 
 
1               20 mg     0.70 ± 0.01      0.73 ± 0.01     0.76 ± 0.01*    0.83 ± 0.02*     0.89 ± 0.02*     0.98 ± 0.02        1.09 ± 0.02*  
1a             20 mg     0.71 ± 0.02      0.76 ± 0.03     0.80 ± 0.03      0.85 ± 0.03*     0.90 ± 0.02*     0.93 ± 0.02        0.99 ± 0.04* 
1b             20 mg     0.67 ± 0.02      0.70 ± 0.02     0.74 ± 0.01*    0.76 ± 0.02*     0.76 ± 0.03*     0.75 ± 0.02*      0.73 ± 0.03* 
1c             20 mg     0.67 ± 0.02      0.70 ± 0.02     0.74 ± 0.01*    0.76 ± 0.02*     0.76 ± 0.03*     0.75 ± 0.02*       0.73 ± 0.03* 
Diclofenac 5mg      0.70 ± 0.02      0.73 ± 0.02     0.75 ± 0.02*    0.77 ± 0.02*     0.80 ± 0.02*     0.82 ± 0.03*       0.88 ± 0.04* 
Sodium 
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Table 2: Percentage Inhibition in formalin induced paw edema by test compounds and 
Diclofenac. 
 
  Test                                                                        % Inhibition 
  Compounds     Dose/kg              0.5 h           1h              2h               3h               4h             5h 
   DMSO             5ml                    -                   -                -                  -                 -                - 
    1                     20 mg                 40              60*           45.8*          38.7            22.2           25 
    1a                   20 mg                 00              40             41.6*          38.7            38.8           46.6* 
    1b                   20 mg                 40              53.3*        62.5*          71*             77.7*         88.5* 
    1c                   20 mg                 00              46.6*        58.3*           45.2*           50*          65.4* 
Diclofenac      5 mg                    40              66.6*        70.8*          67.7*         66.6*          65.4* 
     Sodium          
 
 
    Table-3: Effects of test compounds and Diclofenac on cotton pellet induced granuloma. 
The results given are mean± S.E.M; number of animals used (n=6) 
*P value of < 0.05 was considered as significant in comparison to contro 
                                                                       Weight of cotton pellets    
 
Compounds   Dose/kg        Wet weight                % inhibition                 Dry weight                   % inhibition 
 
Control           5ml              183.7 ± 11.5                         -                       79.3 ± 3.5                               - 
(DMSO) 
1    20 mg            100 ± 9.5*                         45.56                  39.6 ± 2.6*                           50.06    
1a                20 mg            99.5  ± 8.2*                       45.83                  42.0 ± 2.3*                           47.03 
1b                20 mg            79.0 ± 4.5*                        56.99                  30.35 ± 1.6*                         61.72 
1c                20 mg            115.0 ± 10.2*                    37.39                   44.0 ± 2.9*                           44.51 
Diclofenac    5 mg              84.5 ± 6.3                          54.00                  30.0 ± 1.8*                          62.17 
Sodium 
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             Control (DMSO)                                                         Test compound (I) 
 
 
                                                                                                                                                                                         
 
           Test compound (1a)                                                   Test compound (1b)                                    
                 
                                            
 
              Test compound (1c)                                                       Diclofenac sodium                          
                     Fig.2: Cotton pellet surrounded by granuloma tissue. 
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4. DISCUSSION  
The results of this study indicate the synthetic new heterocyclic derivatives of 3-formyl-4-
hydroxycoumarin with addition of different groups possess both acute and chronic 
antiinflammatory activity.  
It is well known that inhibition of edema induced by formalin in rats is one of the most 
suitable test procedures to screen anti-inflammatory and antiarthritic agents, as it closely 
resembles human arthritis. (Greenwald RA et al; 1991) Arthritis induced by formalin is a model 
used for the evaluation of an agent with probable antiproliferative activity (Banerjee S. et al; 
2000). 
        The formalin-induced inflammation in the rats foot may be conveniently divided into two 
parts, the first involving 5-hydroxytryptamine as mediator and the second some mediator which 
is unrelated to 5-hydroxytryptamine. The portion of the total response, which is due to the 
release of 5-hydroxytryptamine, can be prevented by either depleting the skin of 5-
hydroxytryptamine or by giving the rats an antagonist of 5-hydroxytryptamine. It also seems 
probable that the portion of the total response which is due to the " second mediator" can be 
prevented by treatment with certain analgesic-antipyretic drugs (acetylsalicylic acid) and other 
substances like the hydroxybenzoates, the pyrazolones, the flavone and flavanone glycosides are 
inactive against 5-hydroxytryptamine-induced inflammation but they produce their action against 
an formalin-induced inflammation by inactivating the second factor (NORTHOVER B.J et; 
1962). Another possibility is that an antiinflammatory agent might operate by releasing or 
activating some endogenous factor, which is antiinflammatory. It is well known that the 
Salicylates, for example, release both adrenal cortical (Smith, 1953) and adrenal medullary 
hormones (Smith, 1955), and although the adrenal cortical hormones are inactive against 
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formalin-induced inflammation in the rats foot (Northover & Subramanian, 1961a) the adrenal 
medullary are active (NORTHOVER B. J. et al; 1962)  
                The test compound 3-acetoacetyl pyrano [3,2-c] [1] benzopyran 2,5-dione (test 
compound 1) exhibited significant antiinflammatory activity with maximum effect at 3 h. 
Addition of phenylhydrazine  (Test compound 3-acetoacetyl pyrano [3,2-c] [1] benzopyran 2,5-
dione with phenylhydrazine, 1b) markedly improved the antiinflammatory activity, which was as 
good as Diclofenac sodium, the addition of hydrazine hydrate (test compound 3-acetoacetyl 
pyrano [3,2-c] [1] benzopyran 2,5-dione with hydrazine hydrate, 1a) and hydrazinobenzothiazole 
(test compound 3-acetoacetyl pyrano [3,2-c] [1] benzopyran 2,5-dione with 
hydrazinobenzothiazole 1c) also exhibited  significant antiinflammatory activity but to a lesser 
extent. 
         As the test compounds significantly inhibited this model of inflammation, it can be thought 
to possess antiproliferative and antiarthritic activities similar to Diclofenac and Salicylates the 
cyclooxygenase inhibitors. 
 
         The cotton pellet method is widely used to evaluate the transudative and proliferative 
components of the chronic inflammation. Inflammation and granuloma develops during the 
period of several days. The Inflammation involves proliferation of macrophages, Neutrophils and 
fibroblasts, which are basic sources of granuloma formation. The wet weight of the cotton pellets 
correlates with the transuda; the dry weight of the pellets correlates with the amount of the 
granulomatous tissue [Olajide OA et al; 1999 & Olajide OA et al 2000]. Hence, the decrease in 
the weight of granuloma indicates the ability of the test compounds in reducing the synthesis of 
proteins, collagen and infiltration of macrophages. Administration of test compounds (20mg/kg) 
and Diclofenac sodium (5 mg/kg) appear to be effective in inhibiting both the wet weight and dry 
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weight of cotton pellet (table-3). The test compound Ib (20 mg/kg) appears to be equally effective 





        Based on the results it can be concluded that the new heterocyclic derivatives of 3-formyl-4-
hydroxycoumarin possess significant role in inhibition of both acute and chronic phases of 
inflammation. Additions of different functional groups have varying effects. Significant increase 
in anti-inflammatory effect of compound I was observed after addition of phenylhydrazine. 
Further studies to determine the relevance of this finding in humans should be undertaken that 
might result in the development of a potent antiinflammatory and antiarthritic agent with low 
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